Thursday, August 23rd 2018 - Avella EVP of Clinical and Quality Assurance, Eric Sredzinski, was named a finalist for the Phoenix Business Journal Health Care Heroes Awards in the Non-Physician category.
As an executive vice president at Avella Specialty Pharmacy, Eric Sredzinski is responsible for the development and oversight of all clinical programs and services provided by Avella.
NCPDP announced today the Opening Keynote Panel for its 2018 Annual Technology & Business Conference, Industry United to Improve the Patient Journey, May 7-9, 2018, at the Westin Kierland Resort & Spa in Scottsdale, Arizona. The Keynote Panel will address “Data Challenges and Opportunities to Improve the Patient Journey,” on Tuesday, May 8, 2018. Avella founder and chairman of the board, John Musil, will participate on the panel representing specialty pharmacy.
Phoenix, AZ – The Arizona Chapter of The Leukemia & Lymphoma Society (LLS) announced today that Avella Specialty Pharmacy Executive Vice President Hamilton Baiden will serve as the Corporate Walk Chair of the 2018 Greater Phoenix Light The Night.
There are two main ways to expand a company,” says Avella Specialty Pharmacy’s Abby Kaplan. “You can do it organically, or you can do it through acquisition.” In 2016, Avella did both.
Phoenix, AZ -- Avella Specialty Pharmacy announced that it has been named the third largest privately-held company in the state by the Phoenix Business Journal through its Arizona Corporate Excellence (ACE) Awards. Avella moved up from its rank as the fourth largest in 2016 and was also recognized as the sixth fastest-growing company in Arizona this year.
When Rebecca Shanahan was interviewing for her first general counsel position in health care, she was asked about her ability to transition from consumer electronics to such a highly regulated industry.
"I know all about charged-couple devices in a television, and I'm not an engineer, but I know how to sit down with the engineer and really understand [the subject matter] in a way that allows me to apply it to the law,"
Ernst & Young (EY) honored Rebecca M. Shanahan, Esq., the CEO of Avella Specialty Pharmacy and the president of the National Association of Specialty Pharmacy (NASP), with the Entrepreneur of the Year 2017 Award in the Mountain Desert region’s health care category.
Rebecca Shanahan joins three decades of groundbreaking entrepreneurs in healthcare.
Denver, CO – EY just honored Rebecca Shanahan, CEO of Avella Specialty Pharmacy and National Association of Specialty Pharmacy (NASP) president, with the Entrepreneur Of The Year® 2017 Award in the Mountain Desert region’s healthcare category. The award was selected by an independent panel of judges, recognizing entrepreneurs who excel in areas like innovation, financial performance, and personal commitment to their businesses and communities. Avella provides powerful medications used to treat serious illnesses including Hepatitis C, HIV, cancer and other complex, often life-threatening conditions. What began as a single pharmacy in Scottsdale nearly two decades ago is now one of the fastest-growing companies in the nation. Today, Avella houses its own clean room facilities, a national distribution center and community-based pharmacies across multiple states.
June 15, 2017 - Houston, TX, Advanced Pharma, Inc. d/b/a Avella of Houston (“Advanced Pharma”) is voluntarily recalling all unexpired lots of Nitroglycerin products that were produced at Advanced Pharma’s Houston location between March 3, 2017 and May 31, 2017 to the hospital/user level. The recall is being issued based on laboratory test results indicating a lower than expected potency on certain lots of compounded NitroGlycerin Injection which would lead to a lower dose being administered. While the lower than expected potency results affected only certain lots of Nitroglycerin, in an abundance of caution, Advanced Pharma is recalling all unexpired lots of NitroGlycerin. To date, Advanced Pharma has not received any reports of product complaints and/or adverse events related to the products.
